Bladder Cancer - Results from #160

REVIEW UroToday

UroGen Pharma Ahead of Schedule to Complete UGN-102 NDA Submission and Reports 2024 Second Quarter Financial Results and Business Highlights August 15, 2024

Impact of diabetes mellitus on oncologic outcomes in patients receiving robot-assisted radical cystectomy for bladder cancer. August 15, 2024

Non-Muscle Invasive Bladder Cancer: Many More Patients Die With It Than Of It. August 15, 2024

Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis. August 15, 2024

Novel therapeutic regimens in previously untreated metastatic urothelial carcinoma: A systematic review and bayesian network meta-analysis. August 15, 2024

Understanding the microbiome as a mediator of bladder cancer progression and therapeutic response. August 15, 2024

Factors Influencing Patient Decision-Making in the Treatment of Muscle-Invasive Bladder Cancer. August 14, 2024

Perioperative and extended outcomes of patients undergoing parastomal hernia repair following cystectomy and ileal conduit. August 14, 2024

Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy. August 14, 2024

ImmunityBio’s ANKTIVA® Now Covered By More Than a Dozen Insurance Plans Representing Over 100 Million Lives Within Months of FDA Approval August 13, 2024

Do we need a re-TUR after en bloc resection of T1 stage bladder cancer? August 13, 2024

Impact of intra-tumoral immunity on predicting response and survival after neoadjuvant cisplatin-based chemotherapy in patients with muscle invasive bladder cancer. August 13, 2024

The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature. August 12, 2024

Rates of Systemic Therapy for Metastatic Bladder Cancer Are Lower in Unmarried Males and Females. August 12, 2024

Poor prognosis among radiation associated bladder cancer is defined by clinicogenomic features. August 9, 2024

Macrophages directly kill bladder cancer cells through TNF signaling as an early response to BCG therapy. August 9, 2024

Effects of Pathologic Re-Review on Tumor Stage, Grade, and Risk Stratification - Expert Commentary August 8, 2024

Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer. August 8, 2024

Histopathological, Molecular and Clinical Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder (LELC-B). August 8, 2024

Machine learning developed an intratumor heterogeneity signature for predicting clinical outcome and immunotherapy benefit in bladder cancer. August 8, 2024

Page 9 of 517